论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
术中使用右美托咪啶预防老年肺叶切除患者术后认知功能障碍和谵妄:一项倾向评分匹配的回顾性研究
Received 26 December 2023
Accepted for publication 25 March 2024
Published 7 June 2024 Volume 2024:17 Pages 2673—2680
DOI https://doi.org/10.2147/IJGM.S456762
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Scott Fraser
Chaojun Tang, Yalan Li, Yong Lai
Department of Anesthesiology, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, People’s Republic of China
Correspondence: Chaojun Tang, Department of Anesthesiology, The First Affiliated Hospital of Jinan University. 613 West Huangpu Avenue, Guangzhou, 510630, Guangdong Province, People’s Republic of China, Tel +86-751-6926690, Email tangchaojungz@163.com Yalan Li, Department of Anesthesiology, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, People’s Republic of China, Tel +86-751-6926690, Email liyalangzjn@163.com
Purpose: This study aims to investigate whether dexmedetomidine could prevent postoperative cognitive dysfunction and delirium in patients with lobectomy.
Patients and Methods: Patients with lung cancer who underwent thoracoscopic lobectomy under general anesthesia were enrolled in this study and divided into dexmedetomidine group or control group. Propensity-score match (PSM) was used to reduce the bias and imbalance of confounding variables. After PSM, 87 patients in each group were included. Primary outcomes were postoperative cognitive function and delirium. Secondary outcomes include plasma TNF-α, IL-6, and S100 β protein concentrations. Adverse events were also collected.
Results: There were no significant differences in the demographic characteristics and hemodynamic parameters between the two groups. Compared with the control group, the MoCA scores were significantly higher (P< 0.01), while the incidence of delirium (P< 0.01) and the plasma TNF-α (P< 0.01), IL-6 (P< 0.01), and S100 β protein (P< 0.01) concentrations were significantly lower in the dexmedetomidine group at 7 days post-operatively. The incidences of adverse events were similar between the two groups.
Conclusion: Dexmedetomidine could prevent postoperative cognitive dysfunction and delirium in patients with lobectomy by decreasing neuroinflammation.
Keywords: Dexmedetomidine, pneumonectomy, cognitive dysfunction, postoperative cognitive complications, inflammation